1545P CS2009, a novel PD-1/VEGF/CTLA-4 trispecific antibody, in patients with advanced solid tumors: An open-label, multicenter, phase I first-in-human study. - Lemech, C.; Coward, J.; Gao, B.; Park, J.J.W.; Zhou, C.; Moore, M.; Frentzas, S.; Gan, H.K.; Wang, J.; Wang, Q.; Fang, T.; Dai, H.; et al. (Annals of Oncology, 2025)